tiprankstipranks
Trending News
More News >
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Advertisement

Viridian Therapeutics (VRDN) Revenue

Compare
1,365 Followers

Viridian Therapeutics Revenue

Viridian Therapeutics had a revenue of 72.00K in the quarter ending Mar 31, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 302.00K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Viridian Therapeutics had annual revenue of 302.00K with -3.82% growth.
Revenue (ttm)
302.00K
Revenue Growth
4.86%
P/S Ratio
4849.59
Revenue/Employee
$2,112
Employees
143
Market Cap
$1.46B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
302.00K-12.00K-3.82%
Dec 31, 2023
314.00K-1.46M-82.28%
Dec 31, 2022
1.77M-1.19M-40.20%
Dec 31, 2021
2.96M1.91M+182.19%
Dec 31, 2020
1.05M-3.41M-76.46%
Dec 31, 2019
4.46M-3.92M-46.80%
Dec 31, 2018
8.39M4.38M+109.49%
Dec 31, 2017
4.00M666.00K+19.96%
Dec 31, 2016
3.34M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis